• Molecular NamePyruvic acid
  • Synonym2-Oxopropanoate; 2-Oxopropanoic acid; 2-Oxopropionic acid; a-Ketopropionic acid; Acetylformic acid; BTS; Pyroracemic acid; Pyruvate
  • Weight88.062
  • Drugbank_IDDB00119
  • ACS_NO127-17-3
  • Show 3D model
  • LogP (experiment)-1.24
  • LogP (predicted, AB/LogP v2.0)-0.65
  • pkaN/A
  • LogD (pH=7, predicted)-4.67
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)1.06
  • LogSw (predicted, AB/LogsW2.0)123.65
  • Sw (mg/ml) (predicted, ACD/Labs)264.73
  • No.of HBond Donors1
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds1
  • TPSA54.37
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyThose taking large doses of supplemental pyruvate—usually greater than 5 grams daily—have reported gastrointestinal symptoms, including abdominal discomfort and bloating, gas and diarrhea. One child receiving pyruvate intravenously for restrictive cardiomyopathy died.
  • Absorption_valueN/A
  • Absorption (description)Pyruvate is absorbed from the gastrointestinal tract from whence it is transported to the liver via the portal circulation.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmIn the liver, pyruvate is metabolized via several pathways.
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A